Suppr超能文献

机器灌注联合抗生素可预防供体来源的多重耐药菌感染。

Machine perfusion combined with antibiotics prevents donor-derived infections caused by multidrug-resistant bacteria.

机构信息

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, Hubei, P.R. China.

出版信息

Am J Transplant. 2022 Jul;22(7):1791-1803. doi: 10.1111/ajt.17032. Epub 2022 Mar 31.

Abstract

Donor infection affects organ utilization, especially the infections by multidrug-resistant bacteria, which may have disastrous outcomes. We established a rat model, inoculated with Escherichia coli or carbapenem-resistant Klebsiella pneumoniae (CRKP), to investigate whether hypothermic machine perfusion (HMP), normothermic machine perfusion (NMP), or static cold storage (SCS) combined with antibiotic (AB) could eliminate the bacteria. E. coli or CRKP-infected kidneys were treated with cefoperazone-sulbactam and tigecycline, respectively. The HMP+AB and NMP+AB treatments had significant therapeutic effects on E. coli or CRKP infection compared with the SCS+AB treatment. The bacterial load of CRKP-infected kidneys in the HMP+AB (22 050 ± 2884 CFU/g vs. 1900 ± 400 CFU/g, p = .007) and NMP+AB groups (25 433 ± 2059 CFU/g vs. 500 ± 458 CFU/g, p = .002) were significantly reduced, with no statistically significant difference between both groups. Subsequently, the CRKP-infected kidneys of the HMP+AB and SCS+AB groups were transplanted. The rats in the SCS+AB group were severe infected and euthanized on day 4 post-transplant. By contrast, the rats in the HMP+AB group were in good condition. In conclusion, HMP and NMP combined with AB seems to be efficient approaches to decrease bacterial load of infected kidneys. This might lead to higher utilization rates of donors with active infection.

摘要

供体感染会影响器官的利用率,特别是耐多药细菌的感染,这可能会导致灾难性的后果。我们建立了大鼠模型,用大肠杆菌或碳青霉烯类耐药肺炎克雷伯菌(CRKP)接种,以研究低温机器灌注(HMP)、常温机器灌注(NMP)或静态冷保存(SCS)联合抗生素(AB)是否可以消除细菌。用头孢哌酮-舒巴坦和替加环素分别处理大肠杆菌或 CRKP 感染的肾脏。与 SCS+AB 治疗相比,HMP+AB 和 NMP+AB 治疗对大肠杆菌或 CRKP 感染有显著的治疗效果。HMP+AB(22050±2884 CFU/g 比 1900±400 CFU/g,p=0.007)和 NMP+AB 组(25433±2059 CFU/g 比 500±458 CFU/g,p=0.002)中 CRKP 感染肾脏的细菌负荷明显降低,两组之间无统计学差异。随后,将 CRKP 感染的肾脏移植到大鼠体内。SCS+AB 组的大鼠严重感染,并在移植后第 4 天被安乐死。相比之下,HMP+AB 组的大鼠状况良好。总之,HMP 和 NMP 联合 AB 似乎是降低感染肾脏细菌负荷的有效方法。这可能会导致更多患有活动性感染的供体得到更高的利用率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验